Dasatinib (Dasatinib) generic drug price

Dasatinib (Dasatinib) is an oral anti-leukemia drug that belongs to the tyrosine kinase inhibitor class of drugs. It is mainly used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). It blocks the proliferation of leukemia cells by inhibiting abnormally active tyrosine kinases, thereby slowing disease progression.

In China,Dasatinib (Stacer) has been launched and included in the medical insurance catalog, which allows patients to purchase this important anti-leukemia drug at a more reasonable price. According to the price information provided, the price is about four to five thousand yuan per box, but the specific price and medical insurance reimbursement may vary by region and hospital. It is best for patients to consult the local hospital pharmacy to obtain accurate information.

However, the price of foreigndasatinib (Stardas) generic drugs is relatively low, about a few hundred yuan per box. Although low in price, these generic drugs are basically the same as the original drugs in terms of pharmaceutical ingredients, so they can be used as substitutes for domestic original drugs to a certain extent. It is worth noting that choosing generic drugs may also face some quality and reliability problems, so patients should choose carefully when purchasing and make decisions under the guidance of a doctor.

Whether it is an original drug or a generic drug, Dasatinib (Startaxed) is an important anti-leukemia drug and is of great significance to the treatment of patients. However, in addition to price factors, patients should also consider factors such as the efficacy, side effects, and personal financial capabilities of the drug when making choices to ensure the best treatment results. Therefore, when purchasing Dasatinib (Celtaside), it is best for patients to seek advice from their doctor or pharmacist to make an informed choice.